{
    "clinical_study": {
        "@rank": "36847", 
        "acronym": "InterTAK", 
        "brief_summary": {
            "textblock": "This is a multicenter, multinational, prospective and retrospective, observational study of\n      patients with Takotsubo cardiomyopathy (TTC).\n\n      Data on natural profile (demographical characteristics, clinical phenotype, laboratory\n      values, electrocardiography parameters, echocardiography parameters, coronary angiography\n      parameters, medication) and outcome are systematically collected.\n\n      Our aim is to gain a better insight into the clinical profile and pathophysiology of TTC."
        }, 
        "brief_title": "International Takotsubo Registry (InterTAK Registry)", 
        "completion_date": {
            "#text": "December 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Takotsubo Cardiomyopathy", 
        "condition_browse": {
            "mesh_term": [
                "Cardiomyopathies", 
                "Takotsubo Cardiomyopathy"
            ]
        }, 
        "detailed_description": {
            "textblock": "Registry is an open-ended study and eligible individuals are assessed at index event and\n      follow-up on their phenotypical characteristics. Furthermore, outcome data are collected (by\n      clinical visits or telephone follow-up).\n\n      In addition, participants are given the option to consent to the donation of biosamples for\n      the purposes to identify TTC specific biomarkers and mutations (sub-study on behalf of the\n      registry)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria: Mayo Clinic Diagnostic Criteria (Prasad et al. American Heart Journal\n        2008)\n\n          1. Transient hypokinesis, akinesis, or dyskinesis of the left ventricular mid segments\n             with or without apical involvement; the regional wall motion abnormalities extend\n             beyond a single epicardial vascular distribution; a stressful trigger is often, but\n             not always present.*\n\n          2. Absence of obstructive coronary disease or angiographic evidence of acute plaque\n             rupture. \u2020\n\n          3. New electrocardiographic abnormalities (either ST-segment elevation and/or T-wave\n             inversion) or modest elevation in cardiac troponin.\n\n        In both of the above circumstances, the diagnosis of TTC should be made with caution, and\n        a clear stressful precipitating trigger must be sought. * There are rare exceptions to\n        these criteria such as those patients in whom the regional wall motion abnormality is\n        limited to a single coronary territory.\n\n        \u2020 It is possible that a patient with obstructive coronary atherosclerosis may also develop\n        TTC.\n\n        Exclusion criteria: Patients with Myocarditis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Individuals with manifest Takotsubo cardiomyopathy"
            }
        }, 
        "enrollment": {
            "#text": "4000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01947621", 
            "org_study_id": "InterTAK Registry"
        }, 
        "intervention": {
            "intervention_name": "------", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Broken heart syndrome, stress cardiomyopathy", 
        "lastchanged_date": "May 20, 2014", 
        "link": {
            "url": "http://www.takotsubo-registry.com"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Zurich", 
                    "country": "Switzerland", 
                    "state": "ZH", 
                    "zip": "8091"
                }, 
                "name": "University Hospital Zurich, Division of Cardiology"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_groups": "1", 
        "official_title": "International Multicenter Registry on Takotsubo Cardiomyopathy", 
        "overall_contact": {
            "email": "christian.templin@usz.ch", 
            "last_name": "Christian Templin, MD, PhD", 
            "phone": "+41 44 255 95 85"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Zurich, Division of Cardiology", 
            "last_name": "Christian Templin, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To determine the natural history of Takotsubo cardiomyopathy.", 
            "measure": "Natural history of TTC", 
            "safety_issue": "No", 
            "time_frame": "10 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01947621"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Patients will be assessed for cardiovascular complications during hospitalisation and at follow-up (up to 10 years)", 
            "measure": "Cardiovascular complications, recurrence of TTC and all cause mortality", 
            "safety_issue": "No", 
            "time_frame": "at hospitalizsation, short term (1 year) and long term (10 years)"
        }, 
        "source": "University of Zurich", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University of California, Davis", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Hannover Medical School", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Ludwig-Maximilians - University of Munich", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Heidelberg Medical Center", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Schleswig-Holstein", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Charite University, Berlin, Germany", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Kentucky", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Medical University of Cologne", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University Hospital, Saarland", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University Hospital, Essen", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Asklepios Kliniken Hamburg GmbH", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University Hospital Goettingen", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Magdeburg", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Oxford University Hospitals NHS Trust", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Kantonsspital Winterthur KSW", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Turku University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Medical University of Gdansk", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Medical University of Warsaw", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University Hospital, Basel, Switzerland", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Catholic University of the Sacred Heart", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Medical University Innsbruck", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Cardiocentro Ticino", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Luzerner Kantonsspital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Mayo Clinic", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Zurich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Observational Model: Cohort", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}